Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

American Journal of Cardiovascular Drugs

Issue 1/2009

Content (6 Articles)

Current Opinion

Combination Therapy as First-Line Treatment for Hypertension

Michael H. Crawford

Review Article

Non-Hemodynamic Effects of Organic Nitrates and the Distinctive Characteristics of Pentaerithrityl Tetranitrate

Tommaso Gori, Andreas Daiber

Review Article

Management of Angina Pectoris

Siegfried Eckert, Dieter Horstkotte

Original Research Article

Cardiovascular Outcomes in High-Risk Patients without Heart Failure Treated with ARBs

Mohamad M. Al Khalaf, Lukman Thalib, Suhail A. R. Doi

Original Research Article

Extended Dalteparin Prophylaxis for Venous Thromboembolic Events

George Dranitsaris, Carmine Stumpo, Reginald Smith, William Bartle

Original Research Article

Coadministration of Dabigatran Etexilate and Atorvastatin

Joachim Stangier, Karin Rathgen, Hildegard Stähle, Kathrin Reseski, Thomas Körnicke, Willy Roth

Nov 08
Issue: 6/2008
Mar 09
Issue: 2/2009

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits